Male Bladder Microbiome Relates to Lower Urinary Tract Symptoms.


Journal

European urology focus
ISSN: 2405-4569
Titre abrégé: Eur Urol Focus
Pays: Netherlands
ID NLM: 101665661

Informations de publication

Date de publication:
15 03 2020
Historique:
received: 23 05 2018
revised: 23 07 2018
accepted: 03 08 2018
pubmed: 26 8 2018
medline: 21 5 2021
entrez: 26 8 2018
Statut: ppublish

Résumé

In women, compelling evidence associates lower urinary tract microbiota (LUTM) with lower urinary tract symptoms (LUTS); a similar association in men with benign prostate enlargement (BPE) is not established. To determine whether associations exist between LUTM and LUTS. Forty-nine male volunteers, aged 40-85 yr, were recruited from one academic tertiary care center. Twenty-eight patients undergoing BPE/LUTS surgery and 21 undergoing non-BPE/LUTS surgery were stratified by International Prostate Symptom Score (IPSS), and paired voided/catheterized urine specimens were collected for expanded quantitative urine culture (EQUC) and 16S ribosomal RNA gene sequencing. Primary and secondary outcomes were presence of detectable LUTM and specific bacterial members of the LUTM, respectively. Baseline data were compared. Univariable logistic regression models were used to calculate odds ratios (ORs) for IPSS category associated with the presence of bladder microbiota. Relative LUTM proportions were compared with IPSS using chi-square tests. Thirty-nine percent of catheterized and 98% of voided specimens contained LUTM. Catheterized and voided LUTM differed significantly. LUTM was detected in catheterized urine of 22.2% of men with mild LUTS, 30.0% with moderate LUTS, and 57.1% with severe LUTS (p=0.024). Increased IPSS category was associated with significantly higher odds of detectable bacteria (OR: 2.21, 95% confidence interval: 1.09-4.49). Small sample size limited this study, making it unable to identify significant differences in specific bacterial taxa based on IPSS. Voided urine does not adequately characterize the male bladder microbiome. In males with and without BPE, IPSS severity was associated with detectable bacteria in catheterized urine, which samples the bladder. Additional studies are needed to identify specific bladder bacteria associated with LUTS. To study bladder bacteria, urine should be collected with a catheter. Men with severe urinary symptoms are more likely to have detectable bladder bacteria than those with less severe symptoms.

Sections du résumé

BACKGROUND
In women, compelling evidence associates lower urinary tract microbiota (LUTM) with lower urinary tract symptoms (LUTS); a similar association in men with benign prostate enlargement (BPE) is not established.
OBJECTIVE
To determine whether associations exist between LUTM and LUTS.
DESIGN, SETTING, AND PARTICIPANTS
Forty-nine male volunteers, aged 40-85 yr, were recruited from one academic tertiary care center. Twenty-eight patients undergoing BPE/LUTS surgery and 21 undergoing non-BPE/LUTS surgery were stratified by International Prostate Symptom Score (IPSS), and paired voided/catheterized urine specimens were collected for expanded quantitative urine culture (EQUC) and 16S ribosomal RNA gene sequencing.
OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS
Primary and secondary outcomes were presence of detectable LUTM and specific bacterial members of the LUTM, respectively. Baseline data were compared. Univariable logistic regression models were used to calculate odds ratios (ORs) for IPSS category associated with the presence of bladder microbiota. Relative LUTM proportions were compared with IPSS using chi-square tests.
RESULTS AND LIMITATIONS
Thirty-nine percent of catheterized and 98% of voided specimens contained LUTM. Catheterized and voided LUTM differed significantly. LUTM was detected in catheterized urine of 22.2% of men with mild LUTS, 30.0% with moderate LUTS, and 57.1% with severe LUTS (p=0.024). Increased IPSS category was associated with significantly higher odds of detectable bacteria (OR: 2.21, 95% confidence interval: 1.09-4.49). Small sample size limited this study, making it unable to identify significant differences in specific bacterial taxa based on IPSS.
CONCLUSIONS
Voided urine does not adequately characterize the male bladder microbiome. In males with and without BPE, IPSS severity was associated with detectable bacteria in catheterized urine, which samples the bladder. Additional studies are needed to identify specific bladder bacteria associated with LUTS.
PATIENT SUMMARY
To study bladder bacteria, urine should be collected with a catheter. Men with severe urinary symptoms are more likely to have detectable bladder bacteria than those with less severe symptoms.

Identifiants

pubmed: 30143471
pii: S2405-4569(18)30220-7
doi: 10.1016/j.euf.2018.08.001
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

376-382

Informations de copyright

Copyright © 2018 European Association of Urology. Published by Elsevier B.V. All rights reserved.

Auteurs

Petar Bajic (P)

Department of Urology, Loyola University Medical Center, Maywood, Illinois, USA; Department of Microbiology and Immunology, Loyola University Chicago, Maywood, Illinois, USA.

Michelle E Van Kuiken (ME)

Department of Urology, Loyola University Medical Center, Maywood, Illinois, USA; Department of Microbiology and Immunology, Loyola University Chicago, Maywood, Illinois, USA.

Bethany K Burge (BK)

Department of Urology, Loyola University Medical Center, Maywood, Illinois, USA; Department of Microbiology and Immunology, Loyola University Chicago, Maywood, Illinois, USA.

Eric J Kirshenbaum (EJ)

Department of Urology, Loyola University Medical Center, Maywood, Illinois, USA.

Cara J Joyce (CJ)

Department of Public Health Sciences, Loyola University Chicago, Maywood, Illinois, USA.

Alan J Wolfe (AJ)

Department of Microbiology and Immunology, Loyola University Chicago, Maywood, Illinois, USA. Electronic address: awolfe@luc.edu.

Jeffrey D Branch (JD)

Department of Urology, Loyola University Medical Center, Maywood, Illinois, USA.

Larissa Bresler (L)

Department of Urology, Loyola University Medical Center, Maywood, Illinois, USA.

Ahmer V Farooq (AV)

Department of Urology, Loyola University Medical Center, Maywood, Illinois, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH